Feb 12, 2018

Diabetes treating ‘SGLT2 inhibitors’ named among top advances for preventing heart disease

Posted by in category: biotech/medical

SGLT2 inhibitors, a promising class of diabetes drugs, were shown to significantly lower the rates of heart failure and death in the large CVD-REAL study.

Read more

Comments are closed.